Cortalix

Cortalix operates a VHH nanobody discovery and development platform utilizing proprietary synthetic libraries and a sequential ribosomal and phage display pipeline. The company provides services including lead optimization, CDR grafting, and custom engineering for oncology therapeutics, radiopharmaceutical tracers, and CAR-T therapies. Their platform focuses on delivering clinical-ready, humanized candidates for biotechnology and pharmaceutical partners.